Cargando…

SRC Promotes Tamoxifen Resistance in Breast Cancer via Up-Regulating SIRT1

BACKGROUND: Endocrine therapy plays a key role in estrogen receptor-positive breast cancer patients; but, tamoxifen resistance could be a real difficulty for these patients. Several attempts have been made to explore the mechanism and new therapies for these patients. We intend to clarify the expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jun, Xu, Ming, Le, Kehao, Ming, Jie, Guo, Hui, Ruan, Shengnan, Huang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7259490/ https://www.ncbi.nlm.nih.gov/pubmed/32547094 http://dx.doi.org/10.2147/OTT.S245749

Ejemplares similares

CXCR4 Antagonist AMD3100 Reverses the Resistance to Tamoxifen in Breast Cancer via Inhibiting AKT Phosphorylation
por: Zhou, Jun, et al.
Publicado: (2020)

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
por: Tan, Jie, et al.
Publicado: (2018)

A novel chemical, STF-083010, reverses tamoxifen-related drug resistance in breast cancer by inhibiting IRE1/XBP1
por: Ming, Jie, et al.
Publicado: (2015)

Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway
por: Wu, Deng-Pan, et al.
Publicado: (2021)

Src Drives Growth of Antiestrogen Resistant Breast Cancer Cell Lines and Is a Marker for Reduced Benefit of Tamoxifen Treatment
por: Larsen, Sarah L., et al.
Publicado: (2015)

Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway: Erratum
por: Wu, Deng-Pan, et al.
Publicado: (2022)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Sox2 promotes tamoxifen resistance in breast cancer cells
por: Piva, Marco, et al.
Publicado: (2014)

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy
por: Wang, Ji, et al.
Publicado: (2019)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγ*
por: Lü, Mingrong, et al.
Publicado: (2015)

IGFBP-1 Expression Promotes Tamoxifen Resistance in Breast Cancer Cells via Erk Pathway Activation
por: Zheng, Yan, et al.
Publicado: (2020)

TARBP2-Enhanced Resistance during Tamoxifen Treatment in Breast Cancer
por: Wang, Ming-Yang, et al.
Publicado: (2019)

Disruption of the ER-α36-EGFR/HER2 Positive Regulatory Loops Restores Tamoxifen Sensitivity in Tamoxifen Resistance Breast Cancer Cells
por: Yin, Li, et al.
Publicado: (2014)

Combination Treatment of Tamoxifen with Risperidone in Breast Cancer
por: Yeh, Wei-Lan, et al.
Publicado: (2014)

Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway
por: Wu, Zhen-Hua, et al.
Publicado: (2016)

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen
por: CHEN, MING, et al.
Publicado: (2013)

The prognostic role of Sirt1 expression in solid malignancies: a meta-analysis
por: Wang, Changwen, et al.
Publicado: (2017)

Lnc-DC promotes estrogen independent growth and tamoxifen resistance in breast cancer
por: Peng, Wan-Xin, et al.
Publicado: (2021)

Tamoxifen and Src kinase inhibitors as neuroprotective/neuroregenerative drugs after spinal cord injury
por: Salgado, Iris K., et al.
Publicado: (2015)

Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells
por: Moon, Seo Yun, et al.
Publicado: (2021)

HRD1 sensitizes breast cancer cells to Tamoxifen by promoting S100A8 degradation
por: Wang, YanYang, et al.
Publicado: (2017)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3
por: Lee, Jaewon J., et al.
Publicado: (2018)

M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2020)

Correction: M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2022)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer
por: Feng, Qin, et al.
Publicado: (2014)

Molecular mechanisms and mode of tamoxifen resistance in breast cancer
por: Ali, Shazia, et al.
Publicado: (2016)

Association of tamoxifen resistance and lipid reprogramming in breast cancer
por: Hultsch, Susanne, et al.
Publicado: (2018)

Epigenetic Mechanisms of Tamoxifen Resistance in Luminal Breast Cancer
por: Abdel-Hafiz, Hany A.
Publicado: (2017)

Progress in the Understanding of the Mechanism of Tamoxifen Resistance in Breast Cancer
por: Yao, Jingwei, et al.
Publicado: (2020)

Oestrogen Non-Genomic Signalling is Activated in Tamoxifen-Resistant Breast Cancer
por: Poulard, Coralie, et al.
Publicado: (2019)

Oxidative stress contributes to the tamoxifen-induced killing of breast cancer cells: implications for tamoxifen therapy and resistance
por: Bekele, Raie T., et al.
Publicado: (2016)

CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
por: Xu, Siran, et al.
Publicado: (2019)

SRC promotes lipogenesis: implications for obesity and breast cancer
por: Lin, Shu-Yong, et al.
Publicado: (2021)

SIRT1 promotes metastasis of human osteosarcoma cells
por: Zhang, Ning, et al.
Publicado: (2016)

Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells
por: Lv, Chao, et al.
Publicado: (2022)

Effects of Combined Pentadecanoic Acid and Tamoxifen Treatment on Tamoxifen Resistance in MCF−7/SC Breast Cancer Cells
por: To, Ngoc Bao, et al.
Publicado: (2022)

Upregulation of SOX11 enhances tamoxifen resistance and promotes epithelial‐to‐mesenchymal transition via slug in MCF‐7 breast cancer cells
por: Xiao, Yingsheng, et al.
Publicado: (2020)

lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR-125a-5p
por: Liu, Yungyong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7mhi17afhe6f4jqu0pa84ic8t7